ARCHIVES

Niederhuber says his job is easy, but times are hard: NCI may need to cut up to $150 million.

This article is from The Cancer Letter archive.

Vol. 31 No. 45 | December 9, 2005

Download PDF Visit The Full Archive

Related Articles

Arimidex Reduces Relapse Compared To Tamoxifen, Large Study Reports

December 28, 2001

Politics, Short Tempers, Grievances Dominate NIH Panel On Unconventional Medical Practices

September 25, 1992

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

July 26, 2013

NTP Board Approves Concept For New Mutagenesis Assays

January 1, 1988

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

September 15, 2006

NCI To Offer Compromise On Including “Chop-Like Elements” In CCOP, Agrees Consortia “Appropriate”

May 14, 1982